| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7364741 |
Peptides of human Papilloma virus for use in human T cell response inducing compositions |
Apr. 29, 2008 |
| 7364740 |
Molecular differences between species of the M. tuberculosis complex |
Apr. 29, 2008 |
| 7364722 |
Pharmaceutical and cosmetic compositions comprising plgf-1 |
Apr. 29, 2008 |
| 7361635 |
Simultaneous modulation of multiple genes |
Apr. 22, 2008 |
| 7361634 |
Pain-sensitive therapeutic wound dressings |
Apr. 22, 2008 |
| 7361633 |
Screening method and anti-tumor drug candidate obtained therefrom |
Apr. 22, 2008 |
| 7361358 |
Treatment of a facial pain by peripheral administration of a neurotoxin |
Apr. 22, 2008 |
| 7358228 |
Methods of treating pain using neurotrophic factors |
Apr. 15, 2008 |
| 7358227 |
Pharmaceutical compositions comprising bone morphogenetic protein monomers for inhibiting bone formation |
Apr. 15, 2008 |
| 7358226 |
Ultrasonic concentration of drug delivery capsules |
Apr. 15, 2008 |
| 7358225 |
Cloning and recombinant production of CRF receptor(s) |
Apr. 15, 2008 |
| 7358224 |
Class III SLRP agonists for the reduction of blood vessel formation |
Apr. 15, 2008 |
| 7358222 |
Preventing airway mucus production by administration of EGF-R antagonists |
Apr. 15, 2008 |
| 7358088 |
Peptides and compositions which modulate apoptosis |
Apr. 15, 2008 |
| 7358076 |
Sublancin lantibiotic produced by Bacillus subtilis 168 |
Apr. 15, 2008 |
| 7358046 |
Sensitivity test to predict efficacy of anti-cancer therapies |
Apr. 15, 2008 |
| 7357941 |
Method of delivering a bioactive agent with porous .beta.-tricalcium phosphate granules |
Apr. 15, 2008 |
| 7357931 |
Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
Apr. 15, 2008 |
| 7354908 |
Materials and methods for prevention and treatment of RNA viral diseases |
Apr. 8, 2008 |
| 7354903 |
Cosmetic compositions containing short bioactive peptides |
Apr. 8, 2008 |
| 7354901 |
Production of recombinant BMP-2 |
Apr. 8, 2008 |
| 7354899 |
Methods of treating autoimmune diseases comprising administering CXCR4 antagonists |
Apr. 8, 2008 |
| 7354898 |
Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
Apr. 8, 2008 |
| 7354897 |
Method and composition for inhibiting or slowing blood coagulation |
Apr. 8, 2008 |
| 7354896 |
Administration of leptin |
Apr. 8, 2008 |
| 7354895 |
Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
Apr. 8, 2008 |
| 7354722 |
Modulators of Smurf and BMP/TGF.beta. signaling pathways |
Apr. 8, 2008 |
| 7354588 |
Functional derivatives of ICAM-1 with altered ability to bind LFA-1 or HRV |
Apr. 8, 2008 |
| 7354583 |
Antibody-induced apoptosis |
Apr. 8, 2008 |
| 7354582 |
Use of VEGF antagonists for the treatment of malignant gliomas |
Apr. 8, 2008 |
| 7354581 |
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent |
Apr. 8, 2008 |
| 7354580 |
Method of administering and using VEGF inhibitors for the treatment of human cancer |
Apr. 8, 2008 |
| 7354579 |
Method of treating cancer with a VEGF antagonist and an anti-proliferative agent |
Apr. 8, 2008 |
| 7354578 |
Method of tumor regression with VEGF inhibitors |
Apr. 8, 2008 |
| 7354575 |
Method and pharmaceutical composition for treating inflammation |
Apr. 8, 2008 |
| 7351741 |
Compounds and compositions for delivering active agents |
Apr. 1, 2008 |
| 7351689 |
Use of IL-28 and IL-29 to treat cancer and autoimmune disorders |
Apr. 1, 2008 |
| 7351688 |
Compositions and methods for less immunogenic protein formulations |
Apr. 1, 2008 |
| 7351687 |
Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
Apr. 1, 2008 |
| 7351686 |
Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides |
Apr. 1, 2008 |
| 7351422 |
Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
Apr. 1, 2008 |
| 7351411 |
Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF) |
Apr. 1, 2008 |
| 7348312 |
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction |
Mar. 25, 2008 |
| 7348311 |
Derivatives of dehydrodidemnin B |
Mar. 25, 2008 |
| 7348307 |
Methionine aminopeptidase-2 inhibitors and methods of use thereof |
Mar. 25, 2008 |
| 7348306 |
Composition for promoting lacrimal secretion |
Mar. 25, 2008 |
| 7348305 |
Inhibitor of cardiac tachyarrhythmias |
Mar. 25, 2008 |
| 7348009 |
Recombinant allergen with reduced enzymatic activity |
Mar. 25, 2008 |
| 7347999 |
Methods of treatment of hematopoietic disorders |
Mar. 25, 2008 |
| 7347996 |
Avian cytokines, such as IL-12, comprising a p40 and/or p35 subunit and vaccines |
Mar. 25, 2008 |
|
|
|
